2008Chinese Journal of OsteoporosisRequires access

The Effects of alendronate for reducing the risk of osteoporotic vertebral fracture

Tang Ha

Open publisher page 0 citations

Abstract

Osteoporosis has became a serious public health problem in the world. Nowadays it has been paid closely attention to the prevention and treatment of osteoporosis and osteoporotic fracture. Alendronate is a common therapy to treat osteoporosis, which has an evident effect on increasing BMD, and reducing osteoporotic vertebral fractures and new fractures. Compared with other antiresorptive agents, alendronate has a stronger effect on increasing BMD. However, there is no strong evidence that alendronate could prevent adjacent vertebral fracture after vertebral augmentation.

About this research paper

What this paper is about

Osteoporosis has became a serious public health problem in the world. Nowadays it has been paid closely attention to the prevention and treatment of osteoporosis and osteoporotic fracture. Alendronate is a common therapy to treat osteoporosis, which has an evident effect on increasing BMD, and reducing osteoporotic vertebral fractures and new fractures. Compared with other antiresorptive agents, alendronate has a stronger effect on increasing BMD. However, there is no strong evidence that alendronate could prevent adjacent vertebral fracture after vertebral augmentation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Osteoporosis has became a serious public health problem in the world. Nowadays it has been paid closely attention to the prevention and treatment of osteoporosis and osteoporotic fracture. Alendronate is a common therapy to treat osteoporosis, which has an evident effect on increasing BMD, and reducing osteoporotic vertebral fractures and new fractures. Compared with other antiresorptive agents, alendronate has a stronger effect on increasing BMD. However, there is no strong evidence that alendronate could prevent adjacent vertebral fracture after vertebral augmentation.

Key concepts: Osteoporosis, Medicine, Osteoporotic fracture, Dentistry, Internal medicine, Bone mineral

Related papers

Back to paper searchBrowse research topicsOriginal source
The Effects of alendronate for reducing the risk of osteoporotic vertebral fracture — Research Paper | ScholarLens